Andere talen Treace Medical Concepts, Inc.

Aandelen

TMCI

US89455T1097

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
11,53 ^USD	-2,95%		-7,46%	-9,57%

25/03	Treace Medical Concepts behandelt 100.000 patiënten met Lapiplasty Bunion Correction	MT
27/02	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Treace Announces First Annual National Bunion Day	16/04
Treace to Report First Quarter 2024 Financial Results	09/04
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	25/03
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone	25/03
Treace Medical Concepts: Q4 Earnings Snapshot	27/02
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	27/02
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	27/02
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance	27/02
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results	07/02
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes	02/02
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure	02/02
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	02/02
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	01/02
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	01/02
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million	08/01
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	08/01
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	08/01
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference	19/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Treace Medical Concepts, Inc.

Aandelen

TMCI

US89455T1097

Andere talen

Filters